Cargando…
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
PURPOSE: To describe the visual acuity and anatomic outcomes of intravitreal methotrexate (MTX) for the treatment of primary vitreoretinal lymphoma (PVRL). METHODS: Single-center retrospective case series of patients with a diagnosis of PVRL treated with intravitreal MTX. Patient records were review...
Autores principales: | Anthony, Casey L., Bavinger, J. Clay, Shantha, Jessica G., O’Keefe, Ghazala D., Pearce, William A., Voloschin, Alfredo, Grossniklaus, Hans E., Yeh, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645085/ https://www.ncbi.nlm.nih.gov/pubmed/34863313 http://dx.doi.org/10.1186/s40942-021-00346-0 |
Ejemplares similares
-
Multimodal diagnostic imaging in primary vitreoretinal lymphoma
por: Xu, Lucy T., et al.
Publicado: (2022) -
Diagnostic retinal biopsy in the management of secondary non-CNS vitreoretinal lymphoma masquerading as viral retinitis: a case report
por: Rali, Aditya, et al.
Publicado: (2021) -
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
por: Jiang, Tingting, et al.
Publicado: (2022) -
Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
por: Cheng, Chieh‐Lung, et al.
Publicado: (2023) -
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
por: Zhou, Xian, et al.
Publicado: (2020)